| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $53.9M | — |
| R&D Expense | $170.0M | +47.5% |
| SG&A Expense | $77.1M | +52.5% |
| Operating Income | -$193.2M | -16.5% |
| Pre-tax Income | -$172.0M | -12.7% |
| Income Tax | $2.0M | — |
| Net Income | -$174.0M | -14.0% |
| EPS (Basic) | -$2.02 | +2.9% |
| EPS (Diluted) | -$2.02 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $224.5M | +501.5% |
| Current Assets | $744.8M | +72.2% |
| Total Assets | $760.2M | +69.3% |
| Current Liabilities | $78.7M | +123.2% |
| Long-term Debt | $9.5M | +2.0% |
| Total Liabilities | $346.5M | +570.7% |
| Stockholders' Equity | $413.6M | +4.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $134.3M | +207.6% |
| Capital Expenditures | $472K | +181.0% |
| Investing Cash Flow | -$101.6M | -753.0% |
| Financing Cash Flow | $154.4M | +62.9% |
| Free Cash Flow | $133.8M | +207.1% |
| +2.9% |